Company · CIK 1999480
Alto Neuroscience, Inc.
| CIK | 1999480 (SEC EDGAR) |
|---|---|
| Industry (SIC) | 2834 — Pharmaceutical Preparations |
| Incorporated in | DE |
| Business address | CA |
| Listed | ANRO (NYSE) |
| First annual or quarterly report | 2024-03-21 |
Offerings
4 registrations| Registration | Label and status | First filed | Last event | Filings |
|---|---|---|---|---|
| 333-284667 | 2025-02-03 | 2026-07-14 | 3 | |
| 333-294974 | 2026-04-10 | 2026-04-20 | 2 | |
| 333-291834 | 2025-11-28 | 2025-12-10 | 2 | |
| 333-276495 | 2024-01-12 | 2024-02-05 | 5 |
Filings
13| Filed | Filing | Registration | Accession |
|---|---|---|---|
| 2026-07-14 | 424B5Shelf takedown | 333-284667 | 0001104659-26-083268 |
| 2026-04-20 | EFFECTDeclared effective | 333-294974 | 9999999995-26-001257 |
| 2026-04-10 | S-3Shelf registered | 333-294974 | 0001104659-26-041959 |
| 2025-12-10 | EFFECTDeclared effective | 333-291834 | 9999999995-25-003645 |
| 2025-11-28 | S-3Shelf registered | 333-291834 | 0001104659-25-116507 |
| 2025-02-11 | EFFECTDeclared effective | 333-284667 | 9999999995-25-000401 |
| 2025-02-03 | S-3Shelf registered | 333-284667 | 0001193125-25-019267 |
| 2024-02-05 | 424B4Final prospectus | 333-276495 | 0001193125-24-023429 |
| 2024-02-01 | EFFECTDeclared effective | 333-276495 | 9999999995-24-000286 |
| 2024-01-29 | S-1/AAmendment | 333-276495 | 0001193125-24-017660 |
| 2024-01-29 | S-1/AAmendment | 333-276495 | 0001193125-24-017403 |
| 2024-01-12 | S-1Registration filed | 333-276495 | 0001193125-24-007592 |
| 2023-11-22 | DRSDraft made public | 377-06967 | 0000950123-23-011078 |